# EDGAR Filing Document

**Accession Number:** 0002010850
**File Stem:** 0001104659-25-085810
**Filing Date:** 2025-9
**Character Count:** 7026
**Document Hash:** 5ae470c190ef7a05ac252a02d4c3c349
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-085810.hdr.sgml**: 20250902

**ACCESSION NUMBER**: 0001104659-25-085810

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250902

**EFFECTIVENESS DATE**: 20250902

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Decheng Capital LLC
- **CENTRAL INDEX KEY:** 0002010850

**ORGANIZATION NAME:**
- **EIN:** 981027078
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-23697
- **FILM NUMBER:** 251282304

**BUSINESS ADDRESS:**
- **STREET 1:** 3000 SAND HILL RD
- **STREET 2:** BUILDING 2, SUITE 110
- **CITY:** MENLO PARK
- **STATE:** CA
- **ZIP:** 94025
- **BUSINESS PHONE:** 650-382-5514

**MAIL ADDRESS:**
- **STREET 1:** 3000 SAND HILL RD
- **STREET 2:** BUILDING 2, SUITE 110
- **CITY:** MENLO PARK
- **STATE:** CA
- **ZIP:** 94025

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0002010850

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Decheng Capital LLC

**Address:** 3000 Sand Hill Rd, Menlo Park, CA 94025

**Telephone number:** 415-516-0099

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-23697

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                          | CUSIP   | MEETING DATE   | VOTE DESCRIPTION                                     | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| 4D MOLECULAR THERAPEUTICS,INC.          |  | 06/17/2025     | Compensation of executive officers and other matters | SECTION 14A SAY-ON-PAY VOTES |         250000 |                0 |  |                                   250000 | FOR                         |  |
| ACLARIS THERAPEUTICS, INC.              |  | 06/05/2025     | Compensation of executive officers and other matters | SECTION 14A SAY-ON-PAY VOTES |        4041736 |                0 |  |                                  4041736 | FOR                         |  |
| ARCELLX, INC.                           |  | 05/28/2025     | Compensation of executive officers and other matters | SECTION 14A SAY-ON-PAY VOTES |          50000 |                0 |  |                                    50000 | FOR                         |  |
| BIONTECH SE                             |  | 05/16/2025     | Compensation of executive officers and other matters | SECTION 14A SAY-ON-PAY VOTES |          20000 |                0 |  |                                    20000 | FOR                         |  |
| CRINETICS PHARMACEUTICALSINC.           |  | 06/11/2025     | Compensation of executive officers and other matters | SECTION 14A SAY-ON-PAY VOTES |         177958 |                0 |  |                                   177958 | FOR                         |  |
| CYTOKINETICS, INCORPORATED              |  | 05/14/2025     | Compensation of executive officers and other matters | SECTION 14A SAY-ON-PAY VOTES |         100000 |                0 |  |                                   100000 | FOR                         |  |
| EQUILLIUM, INC.                         |  | 05/21/2025     | Compensation of executive officers and other matters | SECTION 14A SAY-ON-PAY VOTES |        3285710 |                0 |  |                                  3285710 | FOR                         |  |
| LYELL IMMUNOPHARMA, INC.                |  | 05/15/2025     | Compensation of executive officers and other matters | SECTION 14A SAY-ON-PAY VOTES |        5795032 |                0 |  |                                  5795032 | FOR                         |  |
| MERUS N.V.                              |  | 05/21/2025     | Compensation of executive officers and other matters | SECTION 14A SAY-ON-PAY VOTES |         189098 |                0 |  |                                   189098 | FOR                         |  |
| MOONLAKEIMMUNOTHERAPEUTICS              |  | 06/05/2025     | Compensation of executive officers and other matters | SECTION 14A SAY-ON-PAY VOTES |         171600 |                0 |  |                                   171600 | FOR                         |  |
| NEWAMSTERDAM PHARMACOMPANY N.V.         |  | 06/04/2025     | Compensation of executive officers and other matters | SECTION 14A SAY-ON-PAY VOTES |         770000 |                0 |  |                                   770000 | FOR                         |  |
| NUVATION BIO INC.                       |  | 05/21/2025     | Compensation of executive officers and other matters | SECTION 14A SAY-ON-PAY VOTES |       25954439 |                0 |  |                                 25954439 | FOR                         |  |
| REVOLUTION MEDICINES, INC.              |  | 06/26/2025     | Compensation of executive officers and other matters | SECTION 14A SAY-ON-PAY VOTES |         226000 |                0 |  |                                   226000 | FOR                         |  |
| ZENTALIS PHARMACEUTICALS,INC.           |  | 06/17/2025     | Compensation of executive officers and other matters | SECTION 14A SAY-ON-PAY VOTES |         565435 |                0 |  |                                   565435 | FOR                         |  |
| Hummingbird Bioscience Holdings Limited |  | 06/30/2025     | Compensation of executive officers and other matters | SECTION 14A SAY-ON-PAY VOTES |        5035190 |                0 |  |                                  5035190 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Decheng Capital LLC

**By (Signature):** Hongbo Bao

**By (Printed Signature):** Hongbo Bao

**By (Title):** Chief Compliance Officer

**Date:** 08/28/2025